234 related articles for article (PubMed ID: 33367811)
1. Fasting Glucose Variation Predicts Microvascular Risk in ACCORD and VADT.
Zhou JJ; Koska J; Bahn G; Reaven P
J Clin Endocrinol Metab; 2021 Mar; 106(4):1150-1162. PubMed ID: 33367811
[TBL] [Abstract][Full Text] [Related]
2. Association of low fasting C-peptide levels with cardiovascular risk, visit-to-visit glucose variation and severe hypoglycemia in the Veterans Affairs Diabetes Trial (VADT).
Koska J; Nuyujukian DS; Bahn GD; Zhou JJ; Reaven PD
Cardiovasc Diabetol; 2021 Dec; 20(1):232. PubMed ID: 34879878
[TBL] [Abstract][Full Text] [Related]
3. Glycemic Variation and Cardiovascular Risk in the Veterans Affairs Diabetes Trial.
Zhou JJ; Schwenke DC; Bahn G; Reaven P;
Diabetes Care; 2018 Oct; 41(10):2187-2194. PubMed ID: 30082325
[TBL] [Abstract][Full Text] [Related]
4. Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial.
Abraira C; Duckworth W; McCarren M; Emanuele N; Arca D; Reda D; Henderson W;
J Diabetes Complications; 2003; 17(6):314-22. PubMed ID: 14583175
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Long-term HbA
Sheng CS; Tian J; Miao Y; Cheng Y; Yang Y; Reaven PD; Bloomgarden ZT; Ning G
Diabetes Care; 2020 Jun; 43(6):1185-1190. PubMed ID: 32229597
[TBL] [Abstract][Full Text] [Related]
6. Effects of intensive glycemic control on microvascular outcomes in type 2 diabetes mellitus are modified by long-term HbA
Wang JM; Miao MY; Jia YP; Wang XW; Wu XB; Wan ZX; Zheng Y; Qin LQ; Li FR; Chen GC
Diabetes Res Clin Pract; 2024 Feb; 208():111100. PubMed ID: 38246509
[TBL] [Abstract][Full Text] [Related]
7. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Moram CBM; Salles GF
Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
[TBL] [Abstract][Full Text] [Related]
8. Blood Pressure Variability and Risk of Heart Failure in ACCORD and the VADT.
Nuyujukian DS; Koska J; Bahn G; Reaven PD; Zhou JJ;
Diabetes Care; 2020 Jul; 43(7):1471-1478. PubMed ID: 32327422
[TBL] [Abstract][Full Text] [Related]
9. The association between fasting plasma glucose variability and incident eGFR decline: evidence from two cohort studies.
Deravi N; Sharifi Y; Koohi F; Zadeh SST; Masrouri S; Azizi F; Hadaegh F
BMC Public Health; 2023 Mar; 23(1):565. PubMed ID: 36973769
[TBL] [Abstract][Full Text] [Related]
10. Association of Both Short-term and Long-term Glycemic Variability With the Development of Microalbuminuria in the ACCORD Trial.
Okuno T; Vansomphone A; Zhang E; Zhou H; Koska J; Reaven P; Zhou JJ
Diabetes; 2023 Dec; 72(12):1864-1869. PubMed ID: 37725902
[TBL] [Abstract][Full Text] [Related]
11. Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes.
Yang CY; Su PF; Hung JY; Ou HT; Kuo S
Cardiovasc Diabetol; 2020 Jul; 19(1):105. PubMed ID: 32631323
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Glycemic Variability and Vascular Complications in Type 2 Diabetes: Post Hoc Analysis of the FIELD Study.
Scott ES; Januszewski AS; O'Connell R; Fulcher G; Scott R; Kesaniemi A; Wu L; Colagiuri S; Keech A; Jenkins AJ
J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32766757
[TBL] [Abstract][Full Text] [Related]
13. Impact of Visit-to-Visit Fasting Plasma Glucose Variability on the Development of Type 2 Diabetes: A Nationwide Population-Based Cohort Study.
Kim JA; Lee JS; Chung HS; Roh E; Lee YB; Hong SH; Kim NH; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi KM
Diabetes Care; 2018 Dec; 41(12):2610-2616. PubMed ID: 30254081
[TBL] [Abstract][Full Text] [Related]
14. Visit-to-visit fasting plasma glucose variability is associated with left ventricular adverse remodeling in diabetic patients with STEMI.
Yang CD; Shen Y; Ding FH; Yang ZK; Hu J; Shen WF; Zhang RY; Lu L; Wang XQ
Cardiovasc Diabetol; 2020 Sep; 19(1):131. PubMed ID: 32878604
[TBL] [Abstract][Full Text] [Related]
15. Visit-to-visit glycemic variability is a strong predictor of chronic obstructive pulmonary disease in patients with type 2 diabetes mellitus: Competing risk analysis using a national cohort from the Taiwan diabetes study.
Chiu HT; Li TC; Li CI; Liu CS; Lin WY; Lin CC
PLoS One; 2017; 12(5):e0177184. PubMed ID: 28489885
[TBL] [Abstract][Full Text] [Related]
16. Glycaemic variation is a predictor of all-cause mortality in the Veteran Affairs Diabetes Trial.
Zhou JJ; Koska J; Bahn G; Reaven P
Diab Vasc Dis Res; 2019 Mar; 16(2):178-185. PubMed ID: 31014099
[TBL] [Abstract][Full Text] [Related]
17. Fasting plasma glucose variability levels and risk of adverse outcomes among patients with type 2 diabetes: A systematic review and meta-analysis.
Zhao Q; Zhou F; Zhang Y; Zhou X; Ying C
Diabetes Res Clin Pract; 2019 Feb; 148():23-31. PubMed ID: 30583033
[TBL] [Abstract][Full Text] [Related]
18. Visit-to-visit fasting plasma glucose variability is an important risk factor for long-term changes in left cardiac structure and function in patients with type 2 diabetes.
Tang X; Zhong J; Zhang H; Luo Y; Liu X; Peng L; Zhang Y; Qian X; Jiang B; Liu J; Li S; Chen Y
Cardiovasc Diabetol; 2019 Apr; 18(1):50. PubMed ID: 30992008
[TBL] [Abstract][Full Text] [Related]
19. Glycemic Variability and Vascular Complications in Patients with Type 2 Diabetes Mellitus.
Caprnda M; Mesarosova D; Ortega PF; Krahulec B; Egom E; Rodrigo L; Kruzliak P; Mozos I; Gaspar L
Folia Med (Plovdiv); 2017 Sep; 59(3):270-278. PubMed ID: 28976897
[TBL] [Abstract][Full Text] [Related]
20. Review of the veteran affairs diabetes trial: Lessons learned.
Tran K; Reaven P
Rev Endocr Metab Disord; 2020 Dec; 21(4):537-546. PubMed ID: 32458291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
